Literature DB >> 24247655

Inherited genetic susceptibility to multiple myeloma.

G J Morgan1, D C Johnson1, N Weinhold2, H Goldschmidt2, O Landgren3, H T Lynch4, K Hemminki5, R S Houlston6.   

Abstract

Although the familial clustering of multiple myeloma (MM) supports the role of inherited susceptibility, only recently has direct evidence for genetic predisposition been demonstrated. A meta-analysis of two genome-wide association (GWA) studies has identified single-nucleotide polymorphisms (SNPs) localising to a number of genomic regions that are robustly associated with MM risk. In this review, we provide an overview of the evidence supporting a genetic contribution to the predisposition to MM and MGUS (monoclonal gammopathy of unknown significance), and the insight this gives into the biological basis of disease aetiology. We also highlight the promise of future approaches to identify further specific risk factors and their potential clinical utility.

Entities:  

Mesh:

Year:  2013        PMID: 24247655     DOI: 10.1038/leu.2013.344

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  106 in total

1.  Temporal development of myeloma in a syngeneic twin pair.

Authors:  Adebayo B Olujohungbe; Tamsin Gledhill; Greta Satchithananathan
Journal:  Br J Haematol       Date:  2006-04       Impact factor: 6.998

2.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Authors:  Zsofia Kote-Jarai; Ali Amin Al Olama; Graham G Giles; Gianluca Severi; Johanna Schleutker; Maren Weischer; Daniele Campa; Elio Riboli; Tim Key; Henrik Gronberg; David J Hunter; Peter Kraft; Michael J Thun; Sue Ingles; Stephen Chanock; Demetrius Albanes; Richard B Hayes; David E Neal; Freddie C Hamdy; Jenny L Donovan; Paul Pharoah; Fredrick Schumacher; Brian E Henderson; Janet L Stanford; Elaine A Ostrander; Karina Dalsgaard Sorensen; Thilo Dörk; Gerald Andriole; Joanne L Dickinson; Cezary Cybulski; Jan Lubinski; Amanda Spurdle; Judith A Clements; Suzanne Chambers; Joanne Aitken; R A Frank Gardiner; Stephen N Thibodeau; Dan Schaid; Esther M John; Christiane Maier; Walther Vogel; Kathleen A Cooney; Jong Y Park; Lisa Cannon-Albright; Hermann Brenner; Tomonori Habuchi; Hong-Wei Zhang; Yong-Jie Lu; Radka Kaneva; Ken Muir; Sara Benlloch; Daniel A Leongamornlert; Edward J Saunders; Malgorzata Tymrakiewicz; Nadiya Mahmud; Michelle Guy; Lynne T O'Brien; Rosemary A Wilkinson; Amanda L Hall; Emma J Sawyer; Tokhir Dadaev; Jonathan Morrison; David P Dearnaley; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Nicholas Van As; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Colin S Cooper; Aritaya Lophatonanon; Melissa C Southey; John L Hopper; Dallas R English; Tiina Wahlfors; Teuvo L J Tammela; Peter Klarskov; Børge G Nordestgaard; M Andreas Røder; Anne Tybjærg-Hansen; Stig E Bojesen; Ruth Travis; Federico Canzian; Rudolf Kaaks; Fredrik Wiklund; Markus Aly; Sara Lindstrom; W Ryan Diver; Susan Gapstur; Mariana C Stern; Roman Corral; Jarmo Virtamo; Angela Cox; Christopher A Haiman; Loic Le Marchand; Liesel Fitzgerald; Suzanne Kolb; Erika M Kwon; Danielle M Karyadi; Torben Falck Orntoft; Michael Borre; Andreas Meyer; Jürgen Serth; Meredith Yeager; Sonja I Berndt; James R Marthick; Briony Patterson; Dominika Wokolorczyk; Jyotsna Batra; Felicity Lose; Shannon K McDonnell; Amit D Joshi; Ahva Shahabi; Antje E Rinckleb; Ana Ray; Thomas A Sellers; Hui-Yi Lin; Robert A Stephenson; James Farnham; Heiko Muller; Dietrich Rothenbacher; Norihiko Tsuchiya; Shintaro Narita; Guang-Wen Cao; Chavdar Slavov; Vanio Mitev; Douglas F Easton; Rosalind A Eeles
Journal:  Nat Genet       Date:  2011-07-10       Impact factor: 38.330

3.  IgA lambda myeloma presenting concurrently in identical twins with subsequent transformation to 'aggressive phase' in one.

Authors:  J A Snowden; M Greaves
Journal:  Clin Lab Haematol       Date:  1995-03

4.  A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.

Authors:  Siwanon Jirawatnotai; Yiduo Hu; Wojciech Michowski; Joshua E Elias; Lisa Becks; Frederic Bienvenu; Agnieszka Zagozdzon; Tapasree Goswami; Yaoyu E Wang; Alan B Clark; Thomas A Kunkel; Tanja van Harn; Bing Xia; Mick Correll; John Quackenbush; David M Livingston; Steven P Gygi; Piotr Sicinski
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

5.  Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM.

Authors:  Sandra Grass; Klaus-Dieter Preuss; Stephan Thome; Dennis D Weisenburger; Vinetta Witt; Jane Lynch; Florian Zettl; Lorenz Trümper; Natalie Fadle; Evi Regitz; Henry Lynch; Michael Pfreundschuh
Journal:  Blood       Date:  2011-05-17       Impact factor: 22.113

6.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors:  Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

7.  Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.

Authors:  Anne J Novak; Jaime R Darce; Bonnie K Arendt; Brandon Harder; Kathy Henderson; Wayne Kindsvogel; Jane A Gross; Philip R Greipp; Diane F Jelinek
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

8.  Occupational and other environmental factors and multiple myeloma: a population based case-control study.

Authors:  M Eriksson; M Karlsson
Journal:  Br J Ind Med       Date:  1992-02

9.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.

Authors:  Daniel Chubb; Niels Weinhold; Peter Broderick; Bowang Chen; David C Johnson; Asta Försti; Jayaram Vijayakrishnan; Gabriele Migliorini; Sara E Dobbins; Amy Holroyd; Dirk Hose; Brian A Walker; Faith E Davies; Walter A Gregory; Graham H Jackson; Julie A Irving; Guy Pratt; Chris Fegan; James Al Fenton; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Christian Straka; Hermann Einsele; Christian Langer; Elisabeth Dörner; James M Allan; Anna Jauch; Gareth J Morgan; Kari Hemminki; Richard S Houlston; Hartmut Goldschmidt
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

10.  Polycomb CBX7 has a unifying role in cellular lifespan.

Authors:  Jesús Gil; David Bernard; Dolores Martínez; David Beach
Journal:  Nat Cell Biol       Date:  2003-11-30       Impact factor: 28.213

View more
  28 in total

1.  Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families.

Authors:  Jazlyn Read; Judith Symmons; Jane M Palmer; Grant W Montgomery; Nicholas G Martin; Nicholas K Hayward
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

Review 2.  Second malignancies in multiple myeloma; emerging patterns and future directions.

Authors:  Kylee Maclachlan; Benjamin Diamond; Francesco Maura; Jens Hillengass; Ingemar Turesson; C Ola Landgren; Dickran Kazandjian
Journal:  Best Pract Res Clin Haematol       Date:  2020-01-11       Impact factor: 3.020

3.  Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.

Authors:  N Weinhold; A Försti; M I da Silva Filho; J Nickel; C Campo; P Hoffmann; M M Nöthen; D Hose; H Goldschmidt; A Jauch; C Langer; U Hegenbart; S O Schönland; K Hemminki
Journal:  Leukemia       Date:  2014-07-03       Impact factor: 11.528

4.  Familial associations of monoclonal gammopathy of unknown significance with autoimmune diseases.

Authors:  K Hemminki; A Försti; K Sundquist; J Sundquist; X Li
Journal:  Leukemia       Date:  2016-02-29       Impact factor: 11.528

5.  Direct evidence for a polygenic etiology in familial multiple myeloma.

Authors:  Britt-Marie Halvarsson; Anna-Karin Wihlborg; Mina Ali; Konstantinos Lemonakis; Ellinor Johnsson; Abhishek Niroula; Carrie Cibulskis; Niels Weinhold; Asta Försti; Evren Alici; Christian Langer; Michael Pfreundschuh; Hartmut Goldschmidt; Ulf-Henrik Mellqvist; Ingemar Turesson; Anders Waage; Kari Hemminki; Todd Golub; Hareth Nahi; Urban Gullberg; Markus Hansson; Björn Nilsson
Journal:  Blood Adv       Date:  2017-04-07

6.  The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study.

Authors:  Gudbjörg Jonsdottir; Sigrún H Lund; Magnus Björkholm; Ingemar Turesson; Malin Hultcrantz; Anna Porwit; Yogesh S Jethava; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood Adv       Date:  2017-11-22

7.  Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.

Authors:  Monika Engelhardt; Gabriele Ihorst; Ola Landgren; Milena Pantic; Heike Reinhardt; Johannes Waldschmidt; Annette M May; Martin Schumacher; Martina Kleber; Ralph Wäsch
Journal:  Haematologica       Date:  2015-07-09       Impact factor: 9.941

8.  Search for familial clustering of multiple myeloma with any cancer.

Authors:  C Frank; M Fallah; T Chen; E K Mai; J Sundquist; A Försti; K Hemminki
Journal:  Leukemia       Date:  2015-10-09       Impact factor: 11.528

9.  Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes.

Authors:  Rosalie Griffin Waller; Robert J Klein; Joseph Vijai; James D McKay; Alyssa Clay-Gilmour; Xiaomu Wei; Michael J Madsen; Douglas W Sborov; Karen Curtin; Susan L Slager; Kenneth Offit; Celine M Vachon; Steven M Lipkin; Charles Dumontet; Nicola J Camp
Journal:  Hum Mol Genet       Date:  2021-06-09       Impact factor: 6.150

10.  Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma.

Authors:  Jonathan S Mitchell; David C Johnson; Kevin Litchfield; Peter Broderick; Niels Weinhold; Faith E Davies; Walter A Gregory; Graham H Jackson; Martin Kaiser; Gareth J Morgan; Richard S Houlston
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.